AnaptysBio, Inc.
ANAB
$26.58
$0.240.91%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 390.90M | 413.05M | 429.49M | 431.15M | 441.24M |
| Total Receivables | 6.85M | 3.27M | 3.18M | 1.52M | 1.42M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 9.08M | 11.68M | 5.87M | 4.48M | 4.55M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 406.84M | 428.00M | 438.54M | 437.15M | 447.21M |
|
|
|||||
| Total Current Assets | 406.84M | 428.00M | 438.54M | 437.15M | 447.21M |
| Net Property, Plant & Equipment | 18.27M | 18.87M | 19.07M | 19.45M | 19.99M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 256.00K | 256.00K | 256.00K | 256.00K | 256.00K |
| Total Assets | 452.39M | 487.33M | 517.10M | 551.79M | 610.38M |
|
|
|||||
| Total Accounts Payable | 4.70M | 6.52M | 4.76M | 3.17M | 2.78M |
| Total Accrued Expenses | 30.51M | 30.46M | 34.69M | 29.67M | 21.63M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.78M | 1.74M | 1.71M | 1.67M | 1.64M |
| Total Finance Division Other Current Liabilities | 456.00K | 459.00K | 472.00K | 1.29M | -- |
| Total Other Current Liabilities | 456.00K | 459.00K | 472.00K | 1.29M | -- |
| Total Current Liabilities | 37.44M | 39.18M | 41.63M | 35.80M | 26.05M |
|
|
|||||
| Total Current Liabilities | 37.44M | 39.18M | 41.63M | 35.80M | 26.05M |
| Long-Term Debt | 310.81M | 311.27M | 310.07M | 307.52M | 304.41M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 16.04M | 16.49M | 16.95M | 17.39M | 17.81M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 364.29M | 366.94M | 368.65M | 360.70M | 348.28M |
|
|
|||||
| Common Stock & APIC | 703.00M | 694.62M | 686.64M | 689.09M | 717.83M |
| Retained Earnings | -614.10M | -571.89M | -534.58M | -494.73M | -450.48M |
| Treasury Stock & Other | -797.00K | -2.35M | -3.61M | -3.27M | -5.25M |
| Total Common Equity | 88.10M | 120.38M | 148.45M | 191.09M | 262.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 88.10M | 120.38M | 148.45M | 191.09M | 262.10M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 88.10M | 120.38M | 148.45M | 191.09M | 262.10M |
|
|
|||||
